75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test whether an increase of the maintenance dose of
clopidogrel from 75 to 150 mg per day results in an additional suppression of ADP-induced
platelet aggregation